Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Lab, |
RCV000498396 | SCV000590855 | pathogenic | not provided | 2016-07-25 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000498396 | SCV000701354 | pathogenic | not provided | 2016-07-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001216679 | SCV001388488 | pathogenic | X-linked Emery-Dreifuss muscular dystrophy | 2023-08-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu84Profs*7) in the EMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EMD are known to be pathogenic (PMID: 24365856). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Emery-Dreifuss muscular dystrophy (PMID: 9536090, 10382910, 21697856, 24375709, 25210889, 31645980). ClinVar contains an entry for this variant (Variation ID: 289486). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV003492030 | SCV003821371 | pathogenic | Emery-Dreifuss muscular dystrophy 1, X-linked | 2022-03-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003401269 | SCV004120544 | pathogenic | EMD-related disorder | 2023-04-25 | criteria provided, single submitter | clinical testing | The EMD c.251_255del5 variant is predicted to result in a frameshift and premature protein termination (p.Leu84Profs*7). This variant has been reported in individuals with Emery-Dreifuss muscular dystrophy (Reported as delTCTAC in Manilal et al 1998. PubMed ID: 9536090; Dai X et al 2019. PubMed ID: 31645980). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in EMD are expected to be pathogenic. This variant is interpreted as pathogenic. |
OMIM | RCV001216679 | SCV000032163 | pathogenic | X-linked Emery-Dreifuss muscular dystrophy | 1998-05-01 | no assertion criteria provided | literature only |